Skip to content
Recall Observatory FDA recall evidence

Drug product

Rizatriptan Benzoate Orally Disintegrating Tablets, USP 5mg, 18 (3 x 6) Unit-Dose Tablets, Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430, Product of India, NDC 68462-467-06

D-0534-2024

May 13, 2024

Class II

Product summary

Firm
Glenmark Pharmaceuticals Inc., USA
Event
Event 94608
Status
Ongoing
Classification
Class II
Quantity
2400 cartons
Official record key
drug-enforcement:D-0534-2024

Official wording

Reason: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that are above the FDA acceptable limit.

Code information: Lot#: 19224857; Exp. 11/2024 Lot#: 19232493; Exp. 6/2025

Distribution pattern: US Nationwide.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    N-Nitroso Desmethyl Rizatriptan Impurity
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations